Advances in DNA sequence specific agents:
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Amsterdam, the Netherlands
Elseview Science B.V.
©2002
|
Ausgabe: | 1st ed |
Schriftenreihe: | Advances in DNA sequence specific agents
v. 4 |
Schlagworte: | |
Online-Zugang: | Volltext |
Beschreibung: | Includes bibliographical references This series encompasses design, synthesis, application, and analytical methods (including clinical and in vitro) for the study of these critical interactions. As our understanding of the genome and proteome expands, general developments in the field of DNA sequence specific interaction are likely to play an increasingly important role. Accordingly, manuscripts have been solicited from experts covering a diverse range of fields, reflecting the cross-disciplinary and dynamic nature of the series. Volume 4 describes work on the modification of DNA by AT specific anticancer drugs, DNA alkylation events which involve metabolite generation, DNA sequence recognition by two selective binders, bulged DNA microenvironments as molecular targets, DNA sequence specific binding by short peptides and the analysis of DNA-protein interactions using DNase I footprinting methodology. Features include: & bull; Expert contributors from the Biomedical world & bull; Emerging areas of drug design and therapeutic applications & bull; Nucleic acid-protein interactions & bull; Color graphics of molecular modeling analyses & bull; New and emerging methodologies |
Beschreibung: | 1 Online-Ressource (viii, 151 pages) |
ISBN: | 9780444510969 0444510966 9780080526133 0080526136 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV042305452 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 150129s2002 |||| o||u| ||||||eng d | ||
020 | |a 9780444510969 |9 978-0-444-51096-9 | ||
020 | |a 0444510966 |9 0-444-51096-6 | ||
020 | |a 9780080526133 |c electronic bk. |9 978-0-08-052613-3 | ||
020 | |a 0080526136 |c electronic bk. |9 0-08-052613-6 | ||
035 | |a (OCoLC)162135933 | ||
035 | |a (DE-599)BVBBV042305452 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 | ||
082 | 0 | |a 572.8/633 |2 22 | |
245 | 1 | 0 | |a Advances in DNA sequence specific agents |c series editor, Graham B. Jones ; volume editor, Brant J. Chapman |
250 | |a 1st ed | ||
264 | 1 | |a Amsterdam, the Netherlands |b Elseview Science B.V. |c ©2002 | |
300 | |a 1 Online-Ressource (viii, 151 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Advances in DNA sequence specific agents |v v. 4 | |
500 | |a Includes bibliographical references | ||
500 | |a This series encompasses design, synthesis, application, and analytical methods (including clinical and in vitro) for the study of these critical interactions. As our understanding of the genome and proteome expands, general developments in the field of DNA sequence specific interaction are likely to play an increasingly important role. Accordingly, manuscripts have been solicited from experts covering a diverse range of fields, reflecting the cross-disciplinary and dynamic nature of the series. Volume 4 describes work on the modification of DNA by AT specific anticancer drugs, DNA alkylation events which involve metabolite generation, DNA sequence recognition by two selective binders, bulged DNA microenvironments as molecular targets, DNA sequence specific binding by short peptides and the analysis of DNA-protein interactions using DNase I footprinting methodology. Features include: & bull; Expert contributors from the Biomedical world & bull; Emerging areas of drug design and therapeutic applications & bull; Nucleic acid-protein interactions & bull; Color graphics of molecular modeling analyses & bull; New and emerging methodologies | ||
650 | 4 | |a DNA. | |
650 | 4 | |a Sequence Analysis, DNA. | |
650 | 7 | |a SCIENCE / Life Sciences / Genetics & Genomics |2 bisacsh | |
650 | 7 | |a DNA. |2 fast | |
650 | 7 | |a Nucleotide sequence |2 fast | |
650 | 4 | |a DNA. | |
650 | 4 | |a Nucleotide sequence | |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780444510969 |x Verlag |3 Volltext |
912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
940 | 1 | |q FAW_PDA_ESD | |
940 | 1 | |q FLA_PDA_ESD | |
999 | |a oai:aleph.bib-bvb.de:BVB01-027742444 |
Datensatz im Suchindex
_version_ | 1804152888546557952 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV042305452 |
collection | ZDB-33-ESD ZDB-33-EBS |
ctrlnum | (OCoLC)162135933 (DE-599)BVBBV042305452 |
dewey-full | 572.8/633 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 572 - Biochemistry |
dewey-raw | 572.8/633 |
dewey-search | 572.8/633 |
dewey-sort | 3572.8 3633 |
dewey-tens | 570 - Biology |
discipline | Biologie |
edition | 1st ed |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02715nmm a2200469zcb4500</leader><controlfield tag="001">BV042305452</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780444510969</subfield><subfield code="9">978-0-444-51096-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0444510966</subfield><subfield code="9">0-444-51096-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080526133</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-08-052613-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080526136</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-08-052613-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)162135933</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042305452</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572.8/633</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in DNA sequence specific agents</subfield><subfield code="c">series editor, Graham B. Jones ; volume editor, Brant J. Chapman</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam, the Netherlands</subfield><subfield code="b">Elseview Science B.V.</subfield><subfield code="c">©2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (viii, 151 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in DNA sequence specific agents</subfield><subfield code="v">v. 4</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This series encompasses design, synthesis, application, and analytical methods (including clinical and in vitro) for the study of these critical interactions. As our understanding of the genome and proteome expands, general developments in the field of DNA sequence specific interaction are likely to play an increasingly important role. Accordingly, manuscripts have been solicited from experts covering a diverse range of fields, reflecting the cross-disciplinary and dynamic nature of the series. Volume 4 describes work on the modification of DNA by AT specific anticancer drugs, DNA alkylation events which involve metabolite generation, DNA sequence recognition by two selective binders, bulged DNA microenvironments as molecular targets, DNA sequence specific binding by short peptides and the analysis of DNA-protein interactions using DNase I footprinting methodology. Features include: & bull; Expert contributors from the Biomedical world & bull; Emerging areas of drug design and therapeutic applications & bull; Nucleic acid-protein interactions & bull; Color graphics of molecular modeling analyses & bull; New and emerging methodologies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sequence Analysis, DNA.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCIENCE / Life Sciences / Genetics & Genomics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DNA.</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nucleotide sequence</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nucleotide sequence</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780444510969</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027742444</subfield></datafield></record></collection> |
id | DE-604.BV042305452 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T01:17:52Z |
institution | BVB |
isbn | 9780444510969 0444510966 9780080526133 0080526136 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027742444 |
oclc_num | 162135933 |
open_access_boolean | |
owner | DE-1046 |
owner_facet | DE-1046 |
physical | 1 Online-Ressource (viii, 151 pages) |
psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD |
publishDate | 2002 |
publishDateSearch | 2002 |
publishDateSort | 2002 |
publisher | Elseview Science B.V. |
record_format | marc |
series2 | Advances in DNA sequence specific agents |
spelling | Advances in DNA sequence specific agents series editor, Graham B. Jones ; volume editor, Brant J. Chapman 1st ed Amsterdam, the Netherlands Elseview Science B.V. ©2002 1 Online-Ressource (viii, 151 pages) txt rdacontent c rdamedia cr rdacarrier Advances in DNA sequence specific agents v. 4 Includes bibliographical references This series encompasses design, synthesis, application, and analytical methods (including clinical and in vitro) for the study of these critical interactions. As our understanding of the genome and proteome expands, general developments in the field of DNA sequence specific interaction are likely to play an increasingly important role. Accordingly, manuscripts have been solicited from experts covering a diverse range of fields, reflecting the cross-disciplinary and dynamic nature of the series. Volume 4 describes work on the modification of DNA by AT specific anticancer drugs, DNA alkylation events which involve metabolite generation, DNA sequence recognition by two selective binders, bulged DNA microenvironments as molecular targets, DNA sequence specific binding by short peptides and the analysis of DNA-protein interactions using DNase I footprinting methodology. Features include: & bull; Expert contributors from the Biomedical world & bull; Emerging areas of drug design and therapeutic applications & bull; Nucleic acid-protein interactions & bull; Color graphics of molecular modeling analyses & bull; New and emerging methodologies DNA. Sequence Analysis, DNA. SCIENCE / Life Sciences / Genetics & Genomics bisacsh DNA. fast Nucleotide sequence fast Nucleotide sequence http://www.sciencedirect.com/science/book/9780444510969 Verlag Volltext |
spellingShingle | Advances in DNA sequence specific agents DNA. Sequence Analysis, DNA. SCIENCE / Life Sciences / Genetics & Genomics bisacsh DNA. fast Nucleotide sequence fast Nucleotide sequence |
title | Advances in DNA sequence specific agents |
title_auth | Advances in DNA sequence specific agents |
title_exact_search | Advances in DNA sequence specific agents |
title_full | Advances in DNA sequence specific agents series editor, Graham B. Jones ; volume editor, Brant J. Chapman |
title_fullStr | Advances in DNA sequence specific agents series editor, Graham B. Jones ; volume editor, Brant J. Chapman |
title_full_unstemmed | Advances in DNA sequence specific agents series editor, Graham B. Jones ; volume editor, Brant J. Chapman |
title_short | Advances in DNA sequence specific agents |
title_sort | advances in dna sequence specific agents |
topic | DNA. Sequence Analysis, DNA. SCIENCE / Life Sciences / Genetics & Genomics bisacsh DNA. fast Nucleotide sequence fast Nucleotide sequence |
topic_facet | DNA. Sequence Analysis, DNA. SCIENCE / Life Sciences / Genetics & Genomics Nucleotide sequence |
url | http://www.sciencedirect.com/science/book/9780444510969 |